4//SEC Filing
Vizirgianakis Stavros G. 4
Accession 0000899243-22-023647
CIK 0001665988other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 8:42 PM ET
Size
9.7 KB
Accession
0000899243-22-023647
Insider Transaction Report
Form 4
Vizirgianakis Stavros G.
Director
Transactions
- Exercise/Conversion
Class A common stock
2022-06-16+965→ 2,781,888 total - Exercise/Conversion
Restricted Stock Units
2022-06-16−965→ 1,930 total→ Class A Common Stock (965 underlying) - Award
Restricted Stock Units
2022-06-17+16,648→ 16,648 total→ Class A Common Stock (16,648 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- [F2]The remaining RSUs shall vest and become exercisable in two approximately equal installments on June 16, 2023 and June 16, 2024, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.
- [F3]The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001559834
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 8:42 PM ET
- Size
- 9.7 KB